Long COVID in Adults: United States, 2022

The National Health Interview Survey of 2022 provides insights into the prevalence of Long COVID among adults in the United States.

Here are the key findings:

  1. Overall Prevalence: In 2022, 6.9% of adults reported having experienced Long COVID at some point, and 3.4% were currently experiencing Long COVID symptoms.
  2. Gender Differences: Women were more likely than men to have ever experienced Long COVID (8.5% vs. 5.2%) and were also more likely to be currently experiencing it (4.4% vs. 2.3%).
  3. Age Factors: Adults aged 35–49 were most likely to have ever had Long COVID (8.9%) or to be currently experiencing it (4.7%). The likelihood of having Long COVID was least among adults aged 65 and older.
  4. Racial and Ethnic Variations: The prevalence of Long COVID varied by race and ethnicity. Asian non-Hispanic adults had the lowest rates of ever having (2.6%) or currently having Long COVID (1.1%). In comparison, Hispanic adults had the highest rates of ever having Long COVID (8.3%), followed by White non-Hispanic (7.1%) and Black non-Hispanic (5.4%) adults.
  5. Income Level Influence: Adults with family incomes at or above 400% of the federal poverty level were less likely to have ever had or be currently experiencing Long COVID compared to those with incomes between 200%–399% of the federal poverty level.
  6. Urbanization Level Impact: The prevalence of Long COVID was higher among adults living in nonmetropolitan and medium/small metropolitan areas compared to those in large central metropolitan areas.
  7. Summary Context: Prevalence estimates were higher among women, adults aged 35–49, and those living in more rural areas. Lower prevalence was observed among Asian adults and those with higher family incomes. Additionally, data from the Nationwide Blood Donor Seroprevalence Survey indicated that as of December 2022, 77.5% of people aged 16 and older had antibodies indicating a previous COVID-19 infection, with adults aged 65 and older, and Asian adults being least likely to have these antibodies.

These findings highlight the varied impact of Long COVID across different demographics and could guide targeted public health strategies and resource allocation.

Read More: https://www.cdc.gov/nchs/data/databriefs/db480.pdf

Leave a comment